Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes

Experimental and Clinical Cardiology

Volumn 16, Issue 3, 2011, Pages

  Tappia, Paramjit S ^a   Thliveris, James ^a   Xu, Yan Jan ^a,b   Aroutiounova, Nina ^a   Dhalla, Naranjan S ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Amino acids; Cardiac dysfunction; Diabetes; Dietary supplementation; Ultrastructure

Indexed keywords

ARGININE; CARNITINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; STREPTOZOCIN; TAURINE; TRIACYLGLYCEROL;

AMINO ACID DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; HEART CATHETERIZATION; HEART FUNCTION; HEART MUSCLE INJURY; HYPERGLYCEMIA; IN VIVO STUDY; LIPID STORAGE; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 80054959353     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-8. (Pubitemid 9228506)
2. Bell DS. Diabetic cardiomyopathy. Diabetes Care 2003;26:2949-51. (Pubitemid 37205574)
3. Bergner DW, Goldberger JJ. Diabetes mellitus and sudden cardiac death: What are the data? Cardiol J 2010;17:117-29.
4. Pierce GN, Beamish RE, Dhalla NS. Heart Dysfunction in Diabetes. CRC Press: Boca Raton, 1988:1-245.
5. Regan TJ. Congestive heart failure in the diabetic. Annu Rev Med 1983,34:161-8.
6. Dhalla NS, Pierce GN, Innes IR, Beamish RE. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1985,1:263-81. (Pubitemid 15236913)
7. Gargiulo P, Jacobellis G, Vaccari V, Andreani D. Diabetic cardiomyopathy: Pathophysiological and clinical aspects. Diab Nutr Metab 1998;11:336-46. (Pubitemid 29255665)
8. Kendler BS. Supplemental conditionally essential nutrients in cardiovascular disease therapy. J Cardiovasc Nurs 2006;21:9-16.
9. Y-J Xu, AS Arneja, PS Tappia, NS Dhalla. The potential health benefits of taurine in cardiovascular disease. Exp Clin Cardiol 2008;13:57-65. (Pubitemid 351865314)
10. Hansen SH. The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 2001;17:330-46. (Pubitemid 33050973)
11. Bouckenooghe T, Remacle C, Reusens B. Is taurine a functional nutrirent? Curr Opin Clin Nutr Metab Care 2006;9:728-33.
12. Appleton J. Arginine: Clinical potential of a semi-essential amino acid. Altern Med 2002;7:512-22. (Pubitemid 36025875)
13. Castillo L, Chapman TE, Sanchez M, et al. Plasma arginine and citruline kinetics in adults given adequate and arginine-free diets. Proc Natl Acad Sci USA 1993;90:7749-53. (Pubitemid 23250028)
14. Castilo L, Ajami A, Branch S, et al. Plasma arginine kinetics in adult man: Response to an arginine-free diet. Metabolism 1994;43:114-22. (Pubitemid 24047114)
15. Menge BA, Schrader H, Ritter PR, et al. Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes. Regul Pept 2010;160:75-80.
16. Kendler BS. Carnitine: An overview of its role in preventive medicine. Prev Med 1986;15:373-90. (Pubitemid 16051427)
17. Malone JI, Schocken DD, Morrison AD, Gilbert-Barness E. Diabetic cardiomyopathy and carnitine deficiency. J Diabetes Complications 1999;13:86-90. (Pubitemid 29320014)
18. Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S. Carnitine deficiency in children and adolescents with type 1 diabetes. J Diabetes Complications 2004;18:271-4. (Pubitemid 39165433)
19. Rodrigues B, Xiang H, McNeill JH. Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 1988;37:1358-64. (Pubitemid 19035986)
20. Rodrigues B, Ross JR, Farahbakshian S, McNeill JH. Effects of in vivo and in vitro treatment with L-carnitine on isolated hearts from chronically diabetic rats. Can J Physiol Pharmacol 1990;68:1085-92. (Pubitemid 20265513)
21. Tappia PS, Asemu G, Aroutiounova N, Dhalla NS. Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy. Mol Cell Biochem 2004;261:193-9. (Pubitemid 39004532)
22. Clark TA, Maddaford TG, Tappia PS, Heyliger CE, Ganguly PK, Pierce GN. Restoration of cardiomyocyte function in streptozotocin-induced diabetic rats after treatment with vanadate in a tea decoction. Curr Pharm Biotechnol 2010;11:906-10.
23. Liu X, Suzuki H, Sethi R, Tappia PS, Takeda N, Dhalla NS. Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes. Ann N Y Acad Sci 2006;1084:141-54. (Pubitemid 47091938)
24. El-Missiry MA, Othman AI, Amer MA. L-arginine ameliorates oxidative stress in alloxan induced experimental diabetes mellitus. J Appl Toxicol 2004;24:93-7. (Pubitemid 38477569)
25. Khaider A, Marx M, Lubec B, Lubec G. L-arginine reduces heart collagen accumulation in the diabetic db/db mouse. Circulation 1994;90:479-83. (Pubitemid 24203715)
26. Li C, Cao L, Zeng Q, et al. Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type 2 receptor expression. Cardiovasc Drugs Therap 2005;18:105-12.
27. Song XD, Chen CZ, Dong B, et al. Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts. Zhonghua Yan Ke Za Zhi 2003;39:605-9.
28. Cheema SK, Dent MR, Saini HK, Aroutiounova N, Tappia PS. Prenatal exposure to maternal undernutrition induces adult cardiac dysfunction. Br J Nutr 2005;93:471-7.
29. Militante JD, Lombardini JB, Schaffer SW. The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus. Cardiovasc Res 2000;46:393-402. (Pubitemid 30319325)
30. You J, Chang KJ. Effects of taurine supplementation on lipid peroxidation, blood glucose and blood lipid metabolism in streptozotocin-induced diabetic rats. Adv Exp Med Biol 1998;442:163-8. (Pubitemid 28313069)
31. Kamata K, Sugiura M, Kojima S, Kasuya Y. Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine. Eur J Pharmacol 1996;303:47-53. (Pubitemid 26191439)
32. Tokunaga H, Yoneda Y, Kuriyama K. Streptozotocin-induced elevation of pancreatic taurine content and suppressive effect of taurine on insulin secretion. Eur J Pharmacol 1983;87:237-43. (Pubitemid 13138541)
33. Soltani N, Qiu H, Aleksic M, et al. GABA exerts protective and regenerative effects on islet β cells and reverses diabetes. Proc Natl Acad Sci USA 2011;108:11692-7.
34. Elizarova EP, Nedosugova LV. First experiments in taurine administration for diabetes mellitus. The effect of erythrocyte membranes. Adv Exp Med Biol 1996;403:583-8. (Pubitemid 26365240)
35. Franconi F, Bennardini F, Mattana A, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: Effects of taurine supplementation. Am J Clin Nutr 1995;5:1115-9.
36. Rodrigues B, Seccombe D, McNeill JH. Lack of effect of oral L-carnitine treatment on lipid metabolism and cardiac function in chronically diabetic rats. Can J Physiol Pharmacol 1990;66:1601-8.
37. González-Ortiz M, Hernández-González SO, Hernández-Salazar E, Martínez-Abundis E. Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients. Ann Nutr Metab 2008;52:335-8.
38. Xu YJ, Saini HK, Zhang M, Elimban V, Dhalla NS. MAPK activation and apoptosis alterations in hearts subjected to calcium paradox are attenuated by taurine. Cardiovasc Res 2006;72:163-74. (Pubitemid 44321917)
39. Ito T, Schaffer SW, Azuma J. The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 2011 Mar 25. [Epub ahead of print]. DOI 10.1007/s00726-011-0883-5.
40. Wink DA, Cook JA, Pacelli R, et al. Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol Lett 1995;82-83:221-6. (Pubitemid 26054708)
41. Rizzo AM, Berselli P, Zava S, et al. Endogenous antioxidants and radical scavengers. Adv Exp Med Biol 2011;698:52-67.
42. Okruhlicova L, Sotnikova R, Stefek M, et al. L-arginine reduces structural remodeling in the diabetic rat myocardium. Methods Find Exp Clin Pharmacol 2002;24:201-7. (Pubitemid 34606349)
43. 2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci USA 1983:80:5412-6.
44. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 1983;244:E528-35. (Pubitemid 13067062)
45. 2+ pump activity during diabetes mellitus. Am J Physiol 1987;252:H540-4.
46. Penpargkul S, Schaibe T, Yipinstol T, Scheuer J. The effect of diabetes on performance and metabolism of rat hearts. Circ Res 1980;47:911-21. (Pubitemid 11217057)
47. Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH. Altered myocardial mechanics in diabetic rat. Circ Res 1980;47:922-33. (Pubitemid 11217058)
48. Dhalla NS, Liu X, Panagia V, Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 1998;40:239-47. (Pubitemid 28506032)
49. Holloway C, Kotsanas G, Wendt I. Acute effects of taurine on intracellular calcium in normal and diabetic cardiac myocytes. Pflugers Arch 1999;438:384-91. (Pubitemid 29361761)
50. Yamauchi-Takihara K, Azuma J, Kishimoto S, Onishi S, Sperelakis N. Taurine prevention of calcium paradox-related damage in cardiac muscle. Its regulatory action on intracellular cation contents. Biochem Pharmacol 1988;37:2651-8.
51. Franconi F, Stendardi I, Matucci R, et al. Inotropic effect of taurine in guinea-pig ventricular strips. Eur J Pharmacol 1984;102:511-4. (Pubitemid 14064091)
52. Satoh H, Nakatani T, Tanaka T, Haga S. Cardiac functions and taurine's actions at different extracellular calcium concentrations in forced swimming stress-loaded rats. Biol Trace Elem Res 2002;87:171-82. (Pubitemid 34721829)
53. Franconi F, Martini F, Stendardi I, et al. Effect of taurine on calcium levels and contractility in guinea pig ventricular strips. Biochem Pharmacol 1982;31:3181-5. (Pubitemid 12031254)
54. Tatsumi T, Matoba S, Kawahara A, et al. Cardioprotective effect of taurine on calcium paradox in streptozotocin-induced diabetic rat hearts. Adv Exp Med Biol 1996;403:539-49. (Pubitemid 26365235)
55. Tahiliani AG, McNeill JH. Effects of triiodothyronine and carnitine on myocardial dysfunction in diabetic rats. Can J Physiol Pharmacol 1986;64:669-72. (Pubitemid 16046234)